Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

Tabla de Políticas Médicas

ID Título Revisión Descripción Acceso
11.003.076 Multibiomarker Disease Activity Blood Test For Rheumatoid Arthritis Jul 2025 Assessment of disease activity in rheumatoid arthritis (ra) is an important component of management with a... Ver
11.003.077 Los ensayos de varios analitos con el análisis algorítmico para predecir el ries Oct 2016 ... Ver
11.003.078 Noninvasive Prenatal Screening For Fetal Aneuploidies And Microdeletions Using Cell-Free Fetal Dna Jun 2026 National guidelines recommend that all pregnant individuals be offered screening for fetal chromosomal... Ver
11.003.079 Invasive Prenatal (Fetal) Diagnostic Testing Sep 2025 Invasive prenatal (fetal) diagnostic testing may be used to identify pathogenic genetic alterations in... Ver
11.003.081 Genetic Testing For Macular Degeneration Apr 2026 Age-related macular degeneration is a complex disease involving both genetic and environmental influences.... Ver
11.003.082 Genetic Testing For Facioscapulohumeral Muscular Dystrophy Mar 2026 Facioscapulohumeral muscular dystrophy (fshd) is an autosomal dominant disease that typically presents before... Ver
11.003.083 Genetic Testing For Charge Syndrome Mar 2026 Charge syndrome is a rare genetic condition associated with multiple congenital anomalies. in many... Ver
11.003.084 Genetic Testing For Idiopathic Dilated Cardiomyopathy Mar 2026 Dilated cardiomyopathy (dcm) is characterized by progressive left ventricular enlargement and systolic... Ver
11.003.085 Genetic Testing For Limb-Girdle Muscular Dystrophies Jun 2024 ... Ver
11.003.086 Kif6 Genotyping For Predicting Cardiovascular Risk Aug 2021 Genetic testing to determine kinesin-like protein 6 (kif6) trp719arg variant status is being evaluated as a... Ver
11.003.087 Molecular Testing In The Management Of Pulmonary Nodules Jun 2026 Plasma-based proteomic screening and gene expression profiling of bronchial brushing are molecular tests... Ver
11.003.088 Molecular Testing For Chronic Heart Failure And Heart Transplant Jun 2021 Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... Ver
11.003.089 Circulating Tumor Dna And Circulating Tumor Cells For Cancer Management (Liquid Biopsy) Sep 2024 Circulating tumor dna (ctdna) and circulating tumor cells (ctcs) in peripheral blood, referred to as... Ver
11.003.090 Gene Expression Profiling For Uveal Melanoma Mar 2025 Uveal melanoma is associated with a high rate of metastatic disease, and survival after the development of... Ver
11.003.092 Proteogenomic Testing For Patients With Cancer Jul 2025 Proteogenomics refers to the integration of genomic information with proteomic and transcriptomic information... Ver
11.003.093 Genetic Testing For Mitochondrial Disorders Oct 2025 Mitochondrial diseases are multisystem diseases that arise from dysfunction in the mitochondrial protein... Ver
11.003.094 Serum Biomarket Panel Testing For Systemic Lupus Erythematosus And Other Connective Tissue Deseases Jul 2025 Systemic lupus erythematosus (sle) is an autoimmune connective tissue disease (ctd) that can be difficult to... Ver
11.003.095 Genotype-Guided Tamoxifen Treatment Sep 2024 Tamoxifen is prescribed as a component of adjuvant endocrine therapy to prevent endocrine receptor-positive... Ver
11.003.096 Miscellaneous Genetic And Molecular Diagnostic Tests Aug 2024 There are numerous commercially available genetic and molecular diagnostic, prognostic, and therapeutic tests... Ver
11.003.097 Gene Expression Profiling For Cutaneous Melanoma Jun 2026 Laboratory tests have been developed that detect the expression of different genes in pigmented lesions or... Ver